Posted: Sun Jul 25, 2004 4:38 am
Sorry, time to leave the board.
-finn
-finn
Welcome to This is MS, the leading forum for Multiple Sclerosis research and support. Join our friendly community of patients, caregivers, and researchers celebrating over 20 years of delivering hope through knowledge.
https://www.thisisms.com/forum/
That's a question that nobody has been able to answer and that's all we have is theory after theory at the present time. What's discouraging is that after 50 years of research, the docs still can't even tell us what causes MS or even what kind of disease it actually is!! Unlike other organs in the body, you can't send a probe into the brain and watch what is going on in order to determine this. All of our info comes "after the fact" and thus the multiple theories.billf wrote:Understood. But isn't it likely that not all the disorders we call MS have this same process?
The abstract concludes:NBQX …resulted in substantial amelioration of disease, increased oligodendrocyte survival, had no effect on lesion size and did not reduce the degree of central nervous system inflammation.
The second is The link between excitotoxic oligodendroglial death and demyelinating diseases by Matutue, C,, et al from Spain in Trends Neurosci. 2001 (PMID 11250007)Thus, glutamate excitotoxicity seems to be an important mechanism in autoimmune demyelination, and its prevention with AMPA/kainate antagonists may prove to be an effective therapy for MS.
Now, I had to look up excitotoxicity to be sure it meant cell death and it does. Check out http://www.alscenter.org/about_als/excite.cfm for a discussion of glutamate and cell death. And, what’s great, per the This is MS article, NBQX is already available. So, it seems to me like NBQX could be a “not auto-immune” neuroprotective treatment of sorts for MS based on this and the New Zealand research. I'm hopingHowever, acute and chronic alterations in glutamate homeostasis can result in overactivation of AMPA and kainate receptors and subsequent excitotoxic oligodendroglial death. Furthermore, demyelinating lesions caused by excitotoxins can be similar to those observed in MS……indicates that oligodendrocyte excitotoxicity could be involved in the pathogenesis of demyelinating disorders.
[*]Lack of vitamin D(?)
In an American study women who took vitamin D supplements were 40 percent less likely to develop MS, but some researchers have doubted the validity of the study.